Yellow Fever Vaccine
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB10805 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 100 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | plasma cell myeloma | KG + DL |
| 2 | indolent plasma cell myeloma | KG + DL |
| 3 | heart disease | KG + DL |
| 4 | Jeune syndrome situs inversus | KG + DL |
| 5 | interventricular septum aneurysm | KG + DL |
| 6 | Pierre Robin syndrome associated with a chromosomal anomaly | KG + DL |
| 7 | hereditary persistence of fetal hemoglobin-sickle cell disease syndrome | KG + DL |
| 8 | sickle cell-beta-thalassemia disease syndrome | KG + DL |
| 9 | sickle cell-hemoglobin E disease syndrome | KG + DL |
| 10 | sickle cell-hemoglobin c disease syndrome | KG + DL |
| 11 | sickle cell-hemoglobin d disease syndrome | KG + DL |
| 12 | partial deletion of the long arm of chromosome 22 | KG + DL |
| 13 | disorder of fucoglycosan synthesis | KG + DL |
| 14 | orofacial clefting syndrome | KG + DL |
| 15 | Laubry-Pezzi syndrome | KG + DL |
| 16 | partial deletion of the long arm of chromosome 7 | KG + DL |
| 17 | genetic syndromic Pierre Robin syndrome | KG + DL |
| 18 | thrombotic disease | KG + DL |
| 19 | pulmonary valve disease | KG + DL |
| 20 | mitral valve disease | KG + DL |
| 21 | gastric linitis plastica | KG + DL |
| 22 | colonic neoplasm | KG + DL |
| 23 | bronchitis | KG + DL |
| 24 | hemoglobinopathy | KG + DL |
| 25 | gastric carcinoma | KG + DL |
| 26 | rectosigmoid junction neoplasm | KG + DL |
| 27 | cecum neuroendocrine tumor G1 | KG + DL |
| 28 | cecal disease | KG + DL |
| 29 | cecum villous adenoma | KG + DL |
| 30 | colonic lymphangioma | KG + DL |
| 31 | lipoma of colon | KG + DL |
| 32 | benign neoplasm of cecum | KG + DL |
| 33 | colon leiomyoma | KG + DL |
| 34 | cavernous hemangioma of colon | KG + DL |
| 35 | beta-thalassemia with other manifestations | KG + DL |
| 36 | partial deletion of the short arm of chromosome 16 | KG + DL |
| 37 | diffuse gastric adenocarcinoma | KG + DL |
| 38 | Hennekam lymphangiectasia-lymphedema syndrome | KG + DL |
| 39 | sickle cell anemia | KG + DL |
| 40 | acquired monoclonal Ig light chain-associated Fanconi syndrome | KG + DL |
| 41 | hemolytic anemia due to glucophosphate isomerase deficiency | KG + DL |
| 42 | female breast carcinoma | KG + DL |
| 43 | urinary bladder neoplasm | KG + DL |
| 44 | pyruvate kinase deficiency of red cells | KG + DL |
| 45 | epithelioid cell uveal melanoma | KG + DL |
| 46 | medullary cystic kidney disease | KG + DL |
| 47 | CMM7 | KG + DL |
| 48 | pediatric leptomeningeal melanoma | KG + DL |
| 49 | pyropoikilocytosis, hereditary | KG + DL |
| 50 | urinary bladder carcinoma | KG + DL |
(Showing top 50 of 100 predictions)
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.